Owen Witte Net Worth & Insider Trades
Owen Witte Allogene Therapeutics, Inc
What is Owen Witte's Net Worth?
The current estimated net worth of Allogene Therapeutics, Inc's Owen Witte is estimated to be about $5.38M . Owen Witte owns about 233,271 units of Allogene Therapeutics, Inc common stock. In the last 4 years at Allogene Therapeutics, Inc, Owen Witte has sold an estimated value of $729.72K worth.
What is Owen Witte's Past Insider Trading?
Owen Witte's largest purchase order was 52,432 units , worth over $270K on October 17, 2018. Owen Witte's largest sale order was 9,969 units , worth over $249.72K on June 11, 2021. In total, Owen Witte has made about 8 transactions over 4 years of their time at Allogene Therapeutics, Inc. Owen Witte usually trades in June, with the busiest year in 2021. The most recent transaction was a sale order of 10,000 units , worth over $117.6K on June 23, 2022.
OWEN WITTE
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Owen Witte's' Mailing Address?
- Mailing address is C/o Allogene Therapeutics, Inc. 210 East Grand Avenue South San Francisco CA 94080 CA
Allogene Therapeutics, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| David Chang, M.D., Ph.D. | 2020 | $675,000 | - | - | $6,550,535 | $506,250 | $83,256 | $7,815,041 |
| David Chang, M.D., Ph.D. | 2019 | $600,000 | - | $4,651,970 | $5,327,140 | $363,000 | $250,000 | $11,192,110 |
| David Chang, M.D., Ph.D. | 2018 | $362,413 | - | $8,948,152 | $3,070,331 | $217,641 | $250,000 | $12,848,537 |
| Eric Schmidt, Ph.D. | 2020 | $440,000 | - | $561,176 | $1,262,643 | $220,000 | - | $2,483,819 |
| Eric Schmidt, Ph.D. | 2019 | $425,000 | - | $1,328,366 | $1,519,700 | $187,000 | - | $3,460,066 |
| Eric Schmidt, Ph.D. | 2018 | $201,232 | - | - | $2,299,658 | $88,099 | - | $2,588,989 |
| Rafael Amado, M.D. | 2020 | $510,000 | $75,000 | $561,176 | $1,262,643 | $255,000 | - | $2,663,819 |
| Rafael Amado, M.D. | 2019 | $145,833 | - | $4,249,976 | $2,759,623 | $71,726 | $225,000 | $7,452,158 |
| Alison Moore, Ph.D. | 2020 | $440,000 | - | $561,176 | $1,262,643 | $220,000 | - | $2,483,819 |
| Alison Moore, Ph.D. | 2019 | $425,000 | - | $996,275 | $1,519,700 | $187,000 | - | $3,127,975 |
| Alison Moore, Ph.D. | 2018 | $233,265 | - | - | $1,401,225 | $102,124 | $100,000 | $1,836,614 |
| Veer Bhavnagri | 2020 | $425,000 | - | $537,490 | $1,211,953 | $212,500 | $9,385 | $2,396,328 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1737287/000173728721000013/allo-20210423xdef14axproxy.htm
What are Allogene Therapeutics, Inc's Past Insider Trades?
Allogene Therapeutics, Inc's most recent insider trade came on August 2, 2022 by Rafael Amado who sold 2,000 units worth $23.94K . In the last 4 years, insiders at Allogene Therapeutics, Inc have sold an estimated value of $151.81M and bought an estimated value of $33.14M worth of shares. Insider trading is most common in March, with the busiest year in 2020. The most active traders at the company are David D Chang, President and CEO, Veer Bhavnagri, General Counsel, and Alison Moore, Chief Technical Officer .
Allogene Therapeutics, Inc. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||